quinapyramine

Known as: 4-amino-6-((2-amino-1,6-dimethyl-4-pyrimidinyl)amino)-1-methylquinaldinium ion 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Trypanosoma evansi infection typically produces wasting disease, but it can also develop into a neurological or… (More)
  • table 2
  • figure 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
Review
2010
Review
2010
In the present article, we summarize our studies of antrycide-resistance of Trypanosoma brucei evansi in four aspects in the last… (More)
  • figure 1
  • figure 2
  • table 1
  • table 3
Is this relevant?
2008
2008
Chemotherapy and chemoprophylaxis are the main methods of trypanosomal control. This study was done to compare the in vivo… (More)
Is this relevant?
2006
2006
Molecular karyotyping by pulsed field gel electrophoresis was used to characterize Trypanosoma evansi isolates. Ten T. evansi… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2004
2004
Using standard parasitological, pathological, haematological and sero-biochemical methods, the trypanocidal effect of… (More)
  • figure 1
  • table 1
Is this relevant?
1999
1999
The drug sensitivities of 16 Trypanosoma evansi isolates from Sudan were examined using two different in vitro assays and rodent… (More)
Is this relevant?
1993
1993
Over a period of 208 days a quinapyramine-resistant population was derived in vivo from a quinapyramine-susceptible clone of… (More)
Is this relevant?
1991
1991
The sensitivity of three Trypanosoma equiperdum clones and thirteen Trypanosoma evansi clones originating from the People's… (More)
Is this relevant?
1989
1989
A Trypanosoma brucei brucei stock resistant to diminazene aceturate, isometamidium chloride, quinapyramine sulfate, and Mel B was… (More)
Is this relevant?
1960
1960
Homidium, quinapyramine, and suramin (Group II compounds) produce their trypanocidal effect in vivo only after a latent period of… (More)
Is this relevant?